News | April 23, 2026
Croda unveils next-gen Matrixyl Neolide to redefine long-lasting skincare performance
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
Move comes amid rising regulatory pressures
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
Subscribe To Our Newsletter & Stay Updated
